Morning. I'm Lindsay A. Rosenwald, Executive Chairman, President, and CEO of Fortress Biotech, and I will be presiding over today's virtual meeting of stockholders. On behalf of our company, I want to welcome you to our 2026 annual meeting of stockholders, which is now formally called to order. We are very pleased to have each of you in attendance at today's virtual meeting. Let me begin by introducing the directors of the company in attendance via remote communication with us today are Jimmie Harvey, Malcolm Hoenlein, Dov Klein, Jay Lobell, Kevin Lorenz, Mike Weiss. Also present here today is Joseph Epstein of KPMG, our independent auditors for the year ending December 31st, 2025, Rakesh Gopalan and David Wolpa of Troutman Pepper Locke LLP, our legal counsel, David Jin, our Chief Financial Officer, who will serve as Secretary of the meeting, and Jennifer Borden, who will serve as Inspector of Elections of the meeting. Our order of business this morning will be to accept the motions to be considered, collect the votes, and then receive a report from the Inspector of Elections about the results. If you have any questions, please submit them to ir@fortressbiotech.com and we will address them after the meeting. This brings us to the first item on the agenda, which is a determination of a quorum. The bylaws and Delaware law provide that the presence in person or by proxy of a majority of the shares of stock issued and outstanding on the record date constitutes a quorum. Jennifer, do we have a quorum? Yes, we do. A majority of the shares of stock issued and outstanding as of the record date, April 21, 2026, are represented at the meeting. Thank you, Jennifer. There are two motions to be voted on by the stockholders. The first motion is the election of Lindsay Rosenwald, Jimmie Harvey, Malcolm Hoenlein, Dov Klein, Jay Lobell, Kevin Lorenz, and Michael Weiss as directors to hold office until the annual meeting in 2027 or until their successors have been elected and qualified. The second motion is to ratify the appointment of KPMG as the company's independent registered public accounting firm for the year ended December 31st, 2026. All stockholders of record as of April 21st, 2026, are entitled to vote at this virtual meeting and have the ability to do so online. If there is any stockholder of record as of April 21st, 2026, who has not voted by proxy and now wants to vote, or who has previously voted by proxy but now wants to change that vote, you may vote online by following the instructions available on the virtual meeting website. If you have already sent in your proxy card and do not want to change your vote, you do not need to do anything now. I'll now call the question on the following resolutions. Resolved that the following persons hereby are elected as directors of the company to serve until 2027 annual meeting of stockholders or their successors are elected and qualified, Lindsay Rosenwald, Jimmie Harvey, Malcolm Hoenlein, Dov Klein, Jay Lobell, Kevin Lorenz, Mike Weiss. Resolved that the appointment of KPMG to serve as the company's independent registered public accounting firm for the year ending December 31st, 2026, is hereby ratified. At this moment, I'm going to officially close the polls. I want to thank everyone for your participation. I'll now ask the Inspector of Elections to report on the vote. Mr. Chairman, based on the preliminary results, all of the nominees for director have been approved. The motion to ratify the appointment of KPMG LLP as the company's independent registered public accounting firm for the 2026 fiscal year has been approved. Thank you, Jennifer. This completes our formal business for today. This concludes the 2026 annual stockholders meeting. Thank you for joining today and for your support of Fortress Biotech Incorporated. Let me now close this meeting. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.